Cargando…

Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting

OBJECTIVE: This study aimed to longitudinally investigate whether ever having used a psychedelic drug can have a protective effect on incidence of suicidality among marginalised women. DESIGN: Longitudinal community-based cohort study. SETTING: Data were drawn from a prospective, community-based coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Argento, Elena, Strathdee, Steffanie A, Tupper, Kenneth, Braschel, Melissa, Wood, Evan, Shannon, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623475/
https://www.ncbi.nlm.nih.gov/pubmed/28939573
http://dx.doi.org/10.1136/bmjopen-2017-016025
_version_ 1783268095854379008
author Argento, Elena
Strathdee, Steffanie A
Tupper, Kenneth
Braschel, Melissa
Wood, Evan
Shannon, Kate
author_facet Argento, Elena
Strathdee, Steffanie A
Tupper, Kenneth
Braschel, Melissa
Wood, Evan
Shannon, Kate
author_sort Argento, Elena
collection PubMed
description OBJECTIVE: This study aimed to longitudinally investigate whether ever having used a psychedelic drug can have a protective effect on incidence of suicidality among marginalised women. DESIGN: Longitudinal community-based cohort study. SETTING: Data were drawn from a prospective, community-based cohort of marginalised women in Metro Vancouver, Canada. PARTICIPANTS: 766 women completed the baseline questionnaire between January 2010 and August 2014. Participants who did not report suicidality at baseline and who completed at least one follow-up visit were included. MAIN OUTCOME MEASURE: Extended Cox regression was used to model predictors of new suicidality (suicide ideation or attempts) over 54-month follow-up. RESULTS: Nearly half (46%; n=355) of participants reported prior suicidality and were thus excluded from the present analyses. Of 290 women eligible at baseline, 11% (n=31) reported recent suicidality during follow-up, with an incidence density of 4.42 per 100 person-years (95% CI 3.10 to 6.30). In multivariable analysis, reported lifetime psychedelic drug use was associated with a 60% reduced hazard for suicidality (adjusted HR (AHR) 0.40; 95% CI 0.17 to 0.94). Crystal methamphetamine use (AHR 3.25; 95% CI 1.47 to 7.21) and childhood abuse (AHR 3.54; 95% CI 1.49 to 8.40) remained independent predictors of suicidality. CONCLUSION: The high rate of suicidality identified in this study is of major concern. Alongside emerging evidence on the potential of psychedelic-assisted therapy to treat some mental illness and addiction issues, our findings demonstrate that naturalistic psychedelic drug use is independently associated with reduced suicidality, while other illicit drug use and childhood trauma predispose women to suicidality. While observational, this study supports calls for further investigation of the therapeutic utility of psychedelic drugs in treating poor mental health and promoting mental wellness.
format Online
Article
Text
id pubmed-5623475
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56234752017-10-10 Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting Argento, Elena Strathdee, Steffanie A Tupper, Kenneth Braschel, Melissa Wood, Evan Shannon, Kate BMJ Open Public Health OBJECTIVE: This study aimed to longitudinally investigate whether ever having used a psychedelic drug can have a protective effect on incidence of suicidality among marginalised women. DESIGN: Longitudinal community-based cohort study. SETTING: Data were drawn from a prospective, community-based cohort of marginalised women in Metro Vancouver, Canada. PARTICIPANTS: 766 women completed the baseline questionnaire between January 2010 and August 2014. Participants who did not report suicidality at baseline and who completed at least one follow-up visit were included. MAIN OUTCOME MEASURE: Extended Cox regression was used to model predictors of new suicidality (suicide ideation or attempts) over 54-month follow-up. RESULTS: Nearly half (46%; n=355) of participants reported prior suicidality and were thus excluded from the present analyses. Of 290 women eligible at baseline, 11% (n=31) reported recent suicidality during follow-up, with an incidence density of 4.42 per 100 person-years (95% CI 3.10 to 6.30). In multivariable analysis, reported lifetime psychedelic drug use was associated with a 60% reduced hazard for suicidality (adjusted HR (AHR) 0.40; 95% CI 0.17 to 0.94). Crystal methamphetamine use (AHR 3.25; 95% CI 1.47 to 7.21) and childhood abuse (AHR 3.54; 95% CI 1.49 to 8.40) remained independent predictors of suicidality. CONCLUSION: The high rate of suicidality identified in this study is of major concern. Alongside emerging evidence on the potential of psychedelic-assisted therapy to treat some mental illness and addiction issues, our findings demonstrate that naturalistic psychedelic drug use is independently associated with reduced suicidality, while other illicit drug use and childhood trauma predispose women to suicidality. While observational, this study supports calls for further investigation of the therapeutic utility of psychedelic drugs in treating poor mental health and promoting mental wellness. BMJ Publishing Group 2017-09-21 /pmc/articles/PMC5623475/ /pubmed/28939573 http://dx.doi.org/10.1136/bmjopen-2017-016025 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Public Health
Argento, Elena
Strathdee, Steffanie A
Tupper, Kenneth
Braschel, Melissa
Wood, Evan
Shannon, Kate
Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title_full Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title_fullStr Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title_full_unstemmed Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title_short Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
title_sort does psychedelic drug use reduce risk of suicidality? evidence from a longitudinal community-based cohort of marginalised women in a canadian setting
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623475/
https://www.ncbi.nlm.nih.gov/pubmed/28939573
http://dx.doi.org/10.1136/bmjopen-2017-016025
work_keys_str_mv AT argentoelena doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting
AT strathdeesteffaniea doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting
AT tupperkenneth doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting
AT braschelmelissa doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting
AT woodevan doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting
AT shannonkate doespsychedelicdrugusereduceriskofsuicidalityevidencefromalongitudinalcommunitybasedcohortofmarginalisedwomeninacanadiansetting